[Surgical and drug therapy of metastatic gastrinoma. Successful palliation over the course of 2 1/2 years].

Abstract

A midaged lady suffering from ulcer disease for about seven years had undergone several surgical and drug therapies without any satisfying success. Then the diagnosis of a gastrinoma was made. By this time there were already multiple liver metastases. First the large supposed primary tumor of the pancreas was resected and within six months later the resection of the progressing liver metastases became necessary because of local tumor complications. The additional drug therapy with octreotide (Sandostatin) given three times daily subcutaneously prevented further tumor progress. Until now this combination of surgical and medical treatment has proved to be a successful palliative method of treating the malignant gastrinoma for 2.5 years.

• Authors: W Miller, M Butters, R Bittner
• Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen (Chirurg) Vol. 66 Issue 5 Pg. 541-4 (May 1995) ISSN: 0009-4722 [Print] Germany
• Vernacular Title: Chirurgische und medikamentöse Therapie beim metastasierenden Gastrinom. Erfolgreiche Palliation über zweieinhalb Jahre.
• PMID: 7541744 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Octreotide

Topics

• Combined Modality Therapy
• Female
• Follow-Up Studies
• Gastrinoma (drug therapy, secondary, surgery)
• Hepatectomy
• Humans
• Liver Neoplasms (drug therapy, secondary, surgery)
• Middle Aged
• Octreotide (administration & dosage)
• Palliative Care
• Pancreatectomy
• Pancreatic Neoplasms (drug therapy, surgery)
• Reoperation